Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Xanodyne (Rights to Amicar)

M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Drug formulation for treatment of bleeding disorder. The drug is used for treatment for bleeding disorder in case of surgical complication.

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Drug Discovery
Acquirer
Primary Office
  • One Riverfront Place
  • Newport, KY 41071
  • United States

Xanodyne (Rights to Amicar) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Xanodyne (Rights to Amicar)‘s full profile, request access.

Request full access to PitchBook

Xanodyne (Rights to Amicar) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Xanodyne (Rights to Amicar)‘s full profile, request access.

Request full access to PitchBook